Lonza Group AG Logo

Lonza Group AG

ISIN

CH0013841017

Ticker

LONN

Sector

Health Care

Sub-Industry

Biotechnology

Country

Switzerland

Year Founded

1897

About Lonza Group AG

Company Description

Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.

Headcount

16,218

Served Area

Worldwide

Headquarters

M√ľnchensteinerstrasse 38
4002, Basel
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
15.11.2023 None Executive member Buy CHF 7,088.00
01.11.2023 None Executive member Buy CHF 95,927.90
23.10.2023 None Executive member Buy CHF 327.30
19.10.2023 None Executive member Buy CHF 19,847.60
18.10.2023 None Non-Executive member Buy CHF 495,880.00
18.10.2023 None Executive member Buy CHF 19,481.00
23.05.2023 None Executive member Sell CHF 533,504.40
19.05.2023 None Executive member Sell CHF 298,737.20
27.01.2022 None Executive member Buy CHF 59,163.24

Capital Markets Information

ISIN

CH0013841017

LEI

549300EFW4H2TCZ71055

Sub-Industry

Biotechnology

Listed Stock Exchange

SIX Swiss Exchange

Stock Index

SMI

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.